
The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

